Global Epigenetics Market Assessment, By Type of Epigenetic Changes [DNA Methylation, Histone Modification, Others], By Product and Service [Enzymes, Kits and Reagents, Instruments and Accessories, Software, Service], By Application [Oncology, Cardiovascular, Immunology, Metabolic, Others], By End-user [Hospitals and Clinics, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
Epigenetics is increasingly being used in the treatment of cancer, which is bolstering the growth of the global epigenetics market.
Home>Industry Reports>Global Epigenetics Market Assessment, Opportunities and Forecast, 2017-2031F
The global epigenetics market is projected to witness a CAGR of 14.73% during the forecast period 2024-2031F, growing from USD 1.54 billion in 2023 to USD 4.61 billion in 2031F. Various factors shape the global epigenetics market, these include exposure to external stimuli, heightened awareness of genetic testing, increased focus on research, the use of epigenetics for early disease detection, biotechnology companies raising funds, the growing popularity of AI-based software, and the growing use of epigenetics for the treatment of cancer.
Major companies in the global epigenetics market are heavily investing in research and development, especially in high-income countries, to promote advancements in the epigenetics industry. The increased exposure of the public to harmful chemicals, such as pesticides and heavy metals, poses a significant threat to their health and well-being by tampering with the DNA and its repair process, leading to mutation in the genes and illnesses. The increased number of illnesses has boosted the need for epigenetic testing assays and kits, further propelling the expansion of the global epigenetics market.
Artificial intelligence is capable of documentation, elucidation, and forecasting of data obtained in the epigenetics sector. The use of AI-based software has transformed the research methods in the field and resulted in boosting innovation and development in the global epigenetics market. In patients suffering from malignant and untreatable cancer, epigenetics has become an important treatment alternative that helps in reversing genetic aberrations that occur in cancer. Applications of epigenetics expand beyond cancer, such as the formation of tailored medicines and early detection of chronic diseases, which, in turn, have led to significant growth in the global epigenetics market.
For example, in January 2024, a genomic medicine startup, Moonwalk Biosciences announced that the company had raised a fund of USD 57 million through Series A fundraising. Through the funding, the company aims to move the products in the epigenetic pipeline and development of epigenetic engineering technology and profiling platform.
Increased Focus on Research
Major companies in the epigenetics industry are investing heavily in research activities to foster innovation, thereby boosting the growth of the global epigenetics market. The potential of epigenetics for discovering new treatment options for diseases, especially diseases short of effective therapies, has garnered attention of the investors. Also, an increased number of research activities has led to the development of new and advanced products that can be used in the treatment of cancer and other chronic diseases. These medications target blood biomarkers in cancer cells, thus representing one of the key factors contributing to the global epigenetics market growth.
For instance, the National Institute of Health (NIH) awarded a grant of USD 374,000 for three years for research focused on epigenetics in June 2022. In this research, the epigenetic changes occurring in many generations of a roundworm are being studied to shed light on epigenetic inheritance for disease and health.
Use in Early Disease Detection
Epigenetics is extremely useful in the early detection of diseases since the underlying causes of a disease can be very well understood by the insights proposed by epigenetics, which give out various reasons for mutations in gene expression that are a result of factors other than changes in the DNA sequence. Epigenetic study aids in decrypting the alterations caused by the epigenetic factors in cell specialization, gene expression, and tissue development processes to help understand the nature of the disease. It is a highly useful method of treatment for a wide range of diseases, including cancer, neurological, and cardiovascular disorders.
For instance, in January 2024, Barts Health NHS Trust and Queen Mary University of London announced their aim to investigate the early signs of disease using AI technologies through a £3 million (USD 3.78 million) partnership. The companies will focus on exploring the capacity of blood markers on DNA.
Growing Popularity of AI-Based Software
Gene is a storehouse of complex information and is responsible for the synthesis of many RNA transcripts and proteins. AI-based epigenetic software can easily manage the data stored in the gene because of its ability to analyze composite epigenetic data with precision and efficiency. The software can easily detect any abnormalities in data and predict the outcome of the disease, boosting the demand for AI-based software in the global epigenetics market. By combining multiomics data, AI can be used in combination with epigenetic information to provide customized solutions that fit each patient’s unique genetic profile. The growing popularity of AI-based software will drive the growth of the global epigenetics market.
For example, FoxO Technologies Inc., an epigenetic biomarker company, announced its partnership with KR8,ai Inc. in January 2024 to secure the license for VITHAR AI Health Coach, KR8's AI-based software that provides epigenetic wellness solutions.
Increased Product Usage for Treating Cancer
Epigenetics is increasingly being used in the treatment of cancer, which is bolstering the growth of the global epigenetics market. Several factors are responsible for the growing preference for epigenetics to cure cancer. Firstly, epigenetic drugs are desirable in the personalized cancer treatment of patients who are resistant to certain drugs because of their ability to reverse drug resistance and can also be used in combination with other therapies. Secondly, unlike irreversible genetic mutations, epigenetic changes are reversible, opening new therapeutic options. Lastly, epigenetic mutations can also be used to stimulate the immunological response of the host boosting antitumoral effects.
For example, in June 2023, the clinical-stage biotechnology company Zenith Epigenetics Ltd. announced progress in the development of ZEN-3694, a BET inhibitor intended for the treatment of NUT Carcinoma.
North America Dominating the Market
North American countries endure a large geriatric population making a large section of the population prone to chronic diseases which greatly affects the healthcare system posing a huge burden on the economy. It is estimated that by 2040, one in five Americans will be 65 years of age or older. Around 23.5% of older Americans reported having fair or poor health in 2022, whereas the percentage of obese people varies from 32% to 46%, which fuels the need for development of innovative solutions. North America has a robust healthcare system housing one of the largest biotechnology companies in the world. The governments support the local companies by helping them launch and improve their products and invest in research and development initiatives. All these factors are responsible for the dominance of North America in the global epigenetics market.
For example, Cardio Diagnostics, Inc., a cardiovascular medicine diagnostic company announced a collaboration with Mana Capital Acquisition Corp, a cardiovascular testing company in May 2022. The corporation aimed to capture a $51 billion epigenetics market share in the US with this partnership.
Future Market Scenario (2024 – 2031F)
- The global epigenetics market will be driven by the development of epigenetic editing tools such as CRISPR-based technologies.
- Increased impact of deteriorating environmental conditions in developing countries will increase the disease susceptibility boosting the growth of the global epigenetics market.
- Increased investigations in transgenerational epigenetic inheritance can create the desired opportunities for the global epigenetics market.
- Integration of epigenetics with proteomics, genomics and transcriptomics will bolster the growth of the global epigenetics market.
Report Scope
“Global Epigenetics Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, that provides an in-depth analysis and qualitative and quantitative assessment of the current state of the global epigenetics market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 7.35% between 2024 and 2031 |
|
Revenue Forecast in 2031 |
USD 5.7 billion |
|
Segments Covered |
Type of Epigenetic Changes, Product and Service, Application, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profile |
Illumina, Inc., Abbott Laboratories, Eli Lilly & Company, GlaxoSmithKline Plc., Johnson & Johnson, Merck & Co. Inc., Mylan NV., Novartis AG, Pfizer, Inc., Bayer AG |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global epigenetics market has been segmented into the following categories:
· By Type of Epigenetic Changes
o DNA Methylation
o Histone Modification
o Others
· By Product and Service
o Enzymes
§ Acetyltransferases
§ Histone Deacetylases
§ Methyltransferases
§ Others
o Kits and Reagents
§ Whole Genome Amplification Kits
§ Bisulfite Conversion Kits
§ Antibodies
§ Others
o Instruments and Accessories
o Software
o Service
· By Application
o Oncology
o Cardiovascular
o Immunology
o Metabolic
o Others
· By End-user
o Hospitals and Clinics
o Biotechnology and Pharmaceutical Companies
o Academic and Research Institutes
o Others
· By Region
o North America
o Europe
o Asia-Pacific
o South America
o Middle East and Africa
Key Players Landscape and Outlook
Major companies in the global epigenetics market are opting for collaborations to grow in the marketplace. Collaborations foster innovation, creativity, and knowledge exchange. By working together, companies can easily overcome challenges and increase their chances of success in the fiercely competitive industry. It helps in improving their reputation and provides more funding opportunities to speed up the research and development efforts. Market leaders are collaborating to automate the epigenetics sector which improves the efficiency of the procedure and increases the outcomes.
For example, Bayer's Consumer Health division formed a partnership with Hurdle, a diagnostic testing company in November 2023 to develop breakthrough technologies in the field of healthy aging. With the help of Hurdle's AI-powered multi-omics the partnership aims to measure biological age using epigenetic biomarkers.
Key Players Operating in the Global Epigenetics Market are:
· Illumina, Inc.
· Abbott Laboratories
· Eli Lilly & Company
· GlaxoSmithKline Plc.
· Johnson & Johnson
· Merck & Co. Inc.
· Mylan NV.
· Novartis AG
· Pfizer, Inc.
· Bayer AG
Markets and Data report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global epigenetics market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Epigenetics Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2. By Type of Epigenetic Changes
4.2.1.DNA Methylation
4.2.2.Histone Modification
4.2.3.Others
4.3. By Product and Service
4.3.1.Enzymes
4.3.1.1. Acetyltransferases
4.3.1.2. Histone Deacetylases
4.3.1.3. Methyltransferases
4.3.1.4. Others
4.3.2.Kits and Reagents
4.3.2.1. Whole Genome Amplification Kits
4.3.2.2. Bisulfite Conversion Kits
4.3.2.3. Antibodies
4.3.2.4. Others
4.3.3.Instruments and Accessories
4.3.4.Software
4.3.5.Service
4.4. By Application
4.4.1.Oncology
4.4.2.Cardiovascular
4.4.3.Immunology
4.4.4.Metabolic
4.4.5.Others
4.5. By End-user
4.5.1.Hospitals and Clinics
4.5.2.Biotechnology and Pharmaceutical Companies
4.5.3.Academic and Research Institutes
4.5.4.Others
4.6. By Region
4.6.1.North America
4.6.2.Europe
4.6.3.Asia-Pacific
4.6.4.South America
4.6.5.Middle East and Africa
4.7. By Company Market Share (%), 2023
5. Global Epigenetics Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Types of Epigenetic Changes
5.1.2.1. DNA Methylation
5.1.2.2. Histone Modification
5.1.2.3. Others
5.1.3.By Product and Service
5.1.3.1. Enzymes
5.1.3.1.1. Acetyltransferases
5.1.3.1.2. Histone Deacetylases
5.1.3.1.3. Methyltransferases
5.1.3.1.4. Others
5.1.3.2. Kits and Reagents
5.1.3.2.1. Whole Genome Amplification Kits
5.1.3.2.2. Bisulfite Conversion Kits
5.1.3.2.3. Antibodies
5.1.3.2.4. Others
5.1.3.3. Instruments and Accessories
5.1.3.4. Software
5.1.3.5. Service
5.1.4.By Application
5.1.4.1. Oncology
5.1.4.2. Cardiovascular
5.1.4.3. Immunology
5.1.4.4. Metabolic
5.1.4.5. Others
5.1.5.By End-user
5.1.5.1. Hospitals and Clinics
5.1.5.2. Biotechnology and Pharmaceutical Companies
5.1.5.3. Academic and Research Institutes
5.1.5.4. Others
5.1.6.United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. By Value
5.1.6.1.2. By Volume
5.1.6.2. By Types of Epigenetic Changes
5.1.6.2.1. DNA Methylation
5.1.6.2.2. Histone Modification
5.1.6.2.3. Others
5.1.6.3. By Product and Service
5.1.6.3.1. Enzymes
5.1.6.3.1.1. Acetyltransferases
5.1.6.3.1.2. Histone Deacetylases
5.1.6.3.1.3. Methyltransferases
5.1.6.3.1.4. Others
5.1.6.3.2. Kits and Reagents
5.1.6.3.2.1. Whole Genome Amplification Kits
5.1.6.3.2.2. Bisulfite Conversion Kits
5.1.6.3.2.3. Antibodies
5.1.6.3.2.4. Others
5.1.6.3.3. Instruments and Accessories
5.1.6.3.4. Software
5.1.6.3.5. Service
5.1.6.4. By Application
5.1.6.4.1. Oncology
5.1.6.4.2. Cardiovascular
5.1.6.4.3. Immunology
5.1.6.4.4. Metabolic
5.1.6.4.5. Others
5.1.6.5. By End-user
5.1.6.5.1. Hospitals and Clinics
5.1.6.5.2. Biotechnology and Pharmaceutical Companies
5.1.6.5.3. Academic and Research Institutes
5.1.6.5.4. Others
5.1.7.Canada
5.1.8.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Types of Epigenetic Changes
6.2. By Product and Service
6.3. By Application
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Patent Landscape
9.2. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Illumina, Inc.
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Abbott Laboratories
13.3. Eli Lilly & Company
13.4. GlaxoSmithKline Plc.
13.5. Johnson & Johnson
13.6. Merck & Co. Inc.
13.7. Mylan NV.
13.8. Novartis AG
13.9. Pfizer, Inc.
13.10. Bayer AG
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures:
Figure 1. Global Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 4. Global Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 5. Global Epigenetics Market Share (%), By Application, 2017-2031F
Figure 6. Global Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 7. Global Epigenetics Market Share (%), By Region, 2017-2031F
Figure 8. North America Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 11. North America Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 12. North America Epigenetics Market Share (%), By Application, 2017-2031F
Figure 13. North America Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 14. North America Epigenetics Market Share (%), By Country, 2017-2031F
Figure 15. United States Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 18. United States Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 19. United States Epigenetics Market Share (%), By Application, 2017-2031F
Figure 20. United States Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 24. Canada Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 25. Canada Epigenetics Market Share (%), By Application, 2017-2031F
Figure 26. Canada Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 30. Mexico Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 31. Mexico Epigenetics Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 36. Europe Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 37. Europe Epigenetics Market Share (%), By Application, 2017-2031F
Figure 38. Europe Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Epigenetics Market Share (%), By Country, 2017-2031F
Figure 40. Germany Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 43. Germany Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 44. Germany Epigenetics Market Share (%), By Application, 2017-2031F
Figure 45. Germany Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 46. France Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 49. France Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 50. France Epigenetics Market Share (%), By Application, 2017-2031F
Figure 51. France Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 55. Italy Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 56. Italy Epigenetics Market Share (%), By Application, 2017-2031F
Figure 57. Italy Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 61. United Kingdom Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 62. United Kingdom Epigenetics Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 67. Russia Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 68. Russia Epigenetics Market Share (%), By Application, 2017-2031F
Figure 69. Russia Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 73. Netherlands Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 74. Netherlands Epigenetics Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 79. Spain Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 80. Spain Epigenetics Market Share (%), By Application, 2017-2031F
Figure 81. Spain Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 85. Turkey Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 86. Turkey Epigenetics Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 91. Poland Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 92. Poland Epigenetics Market Share (%), By Application, 2017-2031F
Figure 93. Poland Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 94. South America Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 97. South America Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 98. South America Epigenetics Market Share (%), By Application, 2017-2031F
Figure 99. South America Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 100. South America Epigenetics Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 104. Brazil Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 105. Brazil Epigenetics Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 110. Argentina Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 111. Argentina Epigenetics Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 116. Asia-Pacific Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 117. Asia-Pacific Epigenetics Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Epigenetics Market Share (%), By Country, 2017-2031F
Figure 120. India Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 123. India Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 124. India Epigenetics Market Share (%), By Application, 2017-2031F
Figure 125. India Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 126. China Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 129. China Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 130. China Epigenetics Market Share (%), By Application, 2017-2031F
Figure 131. China Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 135. Japan Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 136. Japan Epigenetics Market Share (%), By Application, 2017-2031F
Figure 137. Japan Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 141. Australia Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 142. Australia Epigenetics Market Share (%), By Application, 2017-2031F
Figure 143. Australia Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 147. Vietnam Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 148. Vietnam Epigenetics Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 153. South Korea Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 154. South Korea Epigenetics Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 159. Indonesia Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 160. Indonesia Epigenetics Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 165. Philippines Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 166. Philippines Epigenetics Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 171. Middle East & Africa Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 172. Middle East & Africa Epigenetics Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Epigenetics Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 178. Saudi Arabia Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 179. Saudi Arabia Epigenetics Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 184. UAE Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 185. UAE Epigenetics Market Share (%), By Application, 2017-2031F
Figure 186. UAE Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Epigenetics Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Epigenetics Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Epigenetics Market Share (%), By Type of Epigenetic Changes, 2017-2031F
Figure 190. South Africa Epigenetics Market Share (%), By Product and Service, 2017-2031F
Figure 191. South Africa Epigenetics Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Epigenetics Market Share (%), By End-user, 2017-2031F
Figure 193. By Type of Epigenetic Changes Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What regions are covered in the final report for the global epigenetics market?
Who are the key players operating in the global epigenetics market?
What are the major drivers influencing the growth of the global epigenetics market?
What is the market size and growth rate of the global epigenetics market?
See Related Reports
Global Anastomosis Devices Market Assessment, Opportunities and Forecast, 2017-2031F
Global anastomosis devices market is expected to grow due to the rising numbers of diseases, rising demand for surgical procedures, advancements in technology, and the investments made by companies in the research and development.....Read More
Published on
May 2024
4,500
Global Electric Vehicle Battery Swapping Market Assessment, Opportunities and Forecast, 2017-2031F
Increased EV adoption, new fast and bi-directional charging, and extended research and development are expected to fuel the market growth during the forecast period.....Read More
Published on
May 2024
4,500
Global Adaptive Cruise Control (ACC) Market Assessment, Opportunities and Forecast, 2017-2031F
Advanced vehicle security dynamics along with the higher adoption of EVs are anticipated to fuel the market growth.....Read More
Published on
May 2024
4,500
Global Automotive Multi-camera System Market Assessment, Opportunities and Forecast, 2017-2031F
Global automotive multi-camera system market is expected to experience growth due to the rising adoption of ADAS in vehicles, increasing the demand for improved safety features, electric vehicles, and autonomous driving.....Read More
Published on
May 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
